Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.7.2819

Combined Expression of Metastasis Related Markers Naa10p, SNCG and PRL-3 and its Prognostic Value in Breast Cancer Patients  

Min, Li (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education))
Ma, Ruo-Lan (Department of Thoracic Surgery, Peking University Cancer Hospital and Institute)
Yuan, Hua (Breast Center, Peking University Cancer Hospital and Institute)
Liu, Cai-Yun (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education))
Dong, Bing (Department of Pathology, Peking University Cancer Hospital and Institute)
Zhang, Cheng (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education))
Zeng, Yan (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education))
Wang, Li (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education))
Guo, Jian-Ping (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education))
Qu, Li-Ke (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education))
Shou, Cheng-Chao (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education))
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.7, 2015 , pp. 2819-2826 More about this Journal
Abstract
Combinations of multiple biomarkers representing distinct aspects of metastasis may have better prognostic value for breast cancer patients, especially those in late stages. In this study, we evaluated the protein levels of N-${\alpha}$-acetyltransferase 10 protein (Naa10p), synuclein-${\gamma}$ (SNCG), and phosphatase of regenerating liver-3 (PRL-3) in 365 patients with breast cancer by immunohistochemistry. Distinct prognostic subgroups of breast cancer were identified by combination of the three biomarkers. The Naa10p+SNCG-PRL-3-subgroup showed best prognosis with a median distant metastasis-free survival (DMFS) of 140 months, while the Naa10p-SNCG+PRL-3+subgroup had the worst prognosis with a median DMFS of 60.5 months. Multivariate analysis indicated Naa10p, SNCG, PRL-3, and the TNM classification were all independent prognostic factors for both DMFS and overall survival (OS). The three biomarker combination of Naa10p, SNCG and PRL-3 performed better in patients with lymph node metastasis, especially those with more advanced tumors than other subgroups. In conclusion, the combined expression profile of Naa10p, SNCG and PRL-3, alone or in combination with the TNM classification system, may provide a precise estimate of prognosis of breast cancer patients.
Keywords
Combined expression; Naa10p; SNCG; PRL-3; prognosis; breast cancer;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Al-Aidaroos A and Zeng Q (2010). PRL-3 phosphatase and cancer metastasis. J Cell Biochem, 111, 1087-98.   DOI
2 Amsterdam A, Shezen E, Raanan C, et al (2012). Differential staining of gamma synuclein in poorly differentiated compared to highly differentiated colon cancer cells. Oncol Rep, 27, 1451-4.
3 Arnesen T, Kong X, Evjenth R, et al (2005). Interaction between HIF-$1{\alpha}$ (ODD) and hARD1 does not induce acetylation and destabilization of HIF-$1{\alpha}$. FEBS Letters, 579, 6428-32.   DOI
4 Bauer J, Shin D, Chun Y, et al (2009). Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase. PLoS ONE, 4, 7451.   DOI   ScienceOn
5 Bilton R (2005). Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-$1{\alpha}$ and is not induced by hypoxia or HIF. J Biol Chem, 280, 31132-40.   DOI
6 Cox C, Shamehdi C and Glancy J (2011). Sentinel node micrometastasis in breast cancer: clinically significant or not? Breast J, 17, 335-6.   DOI
7 Czekierdowski A, Czekierdowska S, Wielgos M, et al (2006). The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer. Neuro Endocrinol Lett, 27, 381-6.
8 Franceschini A, Szklarczyk D, Frankild S, et al (2012). STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res, 41, 808-15.
9 Gromyko D, Arnesen T, Ryningen A, et al (2010). Depletion of the human $N{\alpha}$-terminal acetyltransferase A induces p53-dependent apoptosis and p53-independent growth inhibition. Int J Cancer, 127, 2777-89.   DOI
10 Guo J, Shou C, Meng L, et al (2007). Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer. Int J Cancer, 121, 1296-305.   DOI
11 Guzinska-Ustymowicz K, Kisluk J, Terlikowski S, et al (2013). Expression of phosphatase of regenerating liver-3 (PRL-3) in endometrioid cancer and lymph nodes metastases. Adv Med Sci, 1, 7-12.
12 Guzinska-Ustymowicz K, Pryczynicz A, Kemona A, Ustymowicz M (2011). Immunohistochemical assessment of PRL-3 (PTP4A3) expression in tumor buds, invasion front, central region of tumor and metastases of colorectal cancer. Adv Med Sci, 56, 39-43.   DOI
13 Hibi T, Mori T, Fukuma M, et al (2009). Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer. Clin Cancer Res, 15, 2864-71.   DOI
14 Holmes M, Chen W, Li L, et al (2010). Aspirin intake and survival after breast cancer. J Clin Oncol, 28, 1467-72.   DOI
15 Jemal A, Bray F, Center M, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
16 Hua K, Tan C, Johansson G, et al (2011). N-${\alpha}$-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42/Rac1 activity. Cancer Cell, 19, 218-31.   DOI
17 Inaba S, Li C, Shi Y, et al (2005). Synuclein inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res Treat, 94, 25-35.   DOI
18 Jafferbhoy S, McWilliams B (2012). Clinical significance and management of sentinel node micrometastasis in invasive breast cancer. Clin Breast Cancer, 12, 308-12.   DOI
19 Jeong J, Bae M, Ahn M, et al (2002). Regulation and destabilization of HIF-1 alpha by ARD1. Cell, 111, 709-20.   DOI
20 Jia T, Liu Y, Liu J, et al (1999). Stimulation of breast cancer invasion and metastasis by synuclein gamma. Cancer Res, 59, 742-7.
21 Kuo H, Lee D, Chen C, et al (2010). ARD1 Stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway. Sci Signal, 3, 9.
22 Lee C, Ou D, Lee S, et al (2010). hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. J Clin Invest, 120, 2920-30.   DOI
23 Lim J, Park J, Chun Y (2006). Human arrest defective 1 acetylates and activates ${\beta}$-catenin, promoting lung cancer cell proliferation. Cancer Res, 66, 10677-82.   DOI
24 Liu C, Dong B, Lu A, et al (2010). Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen. BMC Cancer, 10, 359.   DOI
25 Ohkawa N, Sugisaki S, Tokunaga E, et al (2008). N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic development. Genes Cells, 13, 1171-83.
26 Min L, Xu H, Wang J, et al (2013). N-${\alpha}$-acetyltransferase 10 protein is a negative regulator of 28S proteasome through interaction with $PA28{\beta}$. FEBS Letters, 587, 1630-7.   DOI
27 Ming J, Liu N, Gu Y, et al (2009). PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer. Pathol, 41, 118-26.   DOI
28 Murrayrust T, Oldham N, Hewitson K, et al (2006). Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-$1{\alpha}$ fragments in vitro. FEBS Letters, 580, 1911-8.   DOI
29 Ohkawa N, Sugisaki S, Tokunaga E, et al (2007). ARD1-NAT1 complex regulates neuronal dendritic arborization through ${\alpha}$-tubulin acetylation. Neurosci Res, 58, 88.
30 Pan Z, Bruening W and Godwin A (2006). Involvement of RHO GTPases and ERK in synuclein-gamma enhanced cancer cell motility. Int J Oncol, 29, 1201-5.
31 Peng L, Xing X, Li W, et al (2009). PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling. Mol Cancer, 8, 110.
32 Polato F, Codegoni A, Fruscio R, et al (2005). PRL-3 phosphatase is implicated in ovarian cancer growth. Clin Cancer Res, 11, 6835-9.   DOI
33 Polymeropoulos M, Lavedan C, Leroy E, et al (1997). Mutation in the gamma-synuclein gene identified in families with parkinson's disease. Science, 276, 20457.
34 Siegel R, Naishadham D and Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.   DOI   ScienceOn
35 Rahimzadeh M, Baghestani A, Gohari M, Pourhoseingholi M (2014). Estimation of the cure rate in Iranian breast cancer patients. Asian Pac J Cancer Prev, 15, 4839-42.   DOI   ScienceOn
36 Saini K, Taylor C, Ramirez A, et al (2011). Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries. Ann Oncol, 23, 853-9.
37 Seo J, Cha J, Park J, et al (2010). Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation. Cancer Res, 70, 4422-32.   DOI
38 Singh V, Zhou Y, Marsh J, et al (2007). Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs. Cancer Res, 67, 626-33.   DOI
39 Surgucheva I, Park B, Yue B, et al (2005). Interaction of myocilin with gamma-synuclein affects its secretion and aggregation. Cell Mol Neurobiol, 25, 1009-33.   DOI
40 Vairaktaris E, Yapijakis C, Serefoglou Z, et al (2008). Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol, 134, 821-32.   DOI
41 Wang L (2006). Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome. Ann Oncol, 17, 1517-22.   DOI
42 Wang Z, He Y, Cai S, et al (2008). Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference. Int J Cancer, 123, 1439-47.   DOI
43 Zheng P, Liu Y, Chen L, et al (2010). Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer. J Proteome Res, 9, 4897-905.   DOI
44 Wu K, Huang S, Zhu M, et al (2013). Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer. Med Oncol, 30, 612.   DOI
45 Zeng Y, Liu C, Dong B, et al (2013). Inverse correlation between Naa10p and MMP-9 expression and the combined prognostic value in breast cancer patients. Med Oncol, 30, 562.   DOI